Approval · Notice of Compliance 10812 · 2009
EXTAVIA: Notice of Compliance 10812
Issued November 27, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10812
- Date
- November 27, 2009
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New product name and new manufacturer's name
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EXTAVIA | 02337819 | Cancelled Post Market |
Medicinal ingredients
- INTERFERON BETA-1B 0.3 MG per VIAL